Author:
Burgy Mickaël,Chenard Marie-Pierre,Noël Georges,Bourahla Khalil,Schott Roland
Publisher
Springer Science and Business Media LLC
Reference56 articles.
1. Liwnicz BH, Rubinstein LJ. The pathways of extraneural spread in metastasizing gliomas. Hum Pathol. 1979;10(4):453–67.
2. Koeller KK, Rushing EJ. From the archives of the AFIP: Oligodendroglioma and its variants: radiologic-pathologic correlation. Radiogr Rev Publ Radiol Soc N Am Inc. 2005;25(6):1669–88.
3. Stupp R, Brada M, van den Bent MJ, Tonn J-C, Pentheroudakis G, ESMO Guidelines Working Group. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii93–101.
4. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M, et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res. 2006;66(20):9852–61.
5. Choon A, Roepke JE. Importance of immunohistochemical staining in metastatic anaplastic oligodendroglioma. Arch Pathol Lab Med. 2004;128(4):489–90.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献